Top China ADR Portal

China ADR stock research

Mindray 2010 Q1 disappoints, guides higher

E-mail Print PDF

 

pharmatech_1 May 11, 2010 (Chinavestor) Shares of Mindray Medical (NYSE:MR), a Chinese medical device manufacturer, fell -11.6% at the open on Tuesday following 2010 first quarter financial results. The company reported slight revenue and profit growth from 2009 Q1 but a significant decline from previous quarter.

 

MR_2010511_price1

Source: Reuters.com

Mindray Medical (NYSE:MR) said 2010 first quarter revenues reached $145.8 million vs. $188.8 million last quarter. Net income rose $36.197 million from $25.341 million a year ago but fell short of $70.4 million last quarter.

The best part of the announcement was a reaffirmation of previous guidance. The company expects 2010 full year revenue and net income growth of 17% from 2009 level. This translates to $185 million in revenues and $.46 EPS for the upcoming quarter - colored blue in the following chart.

MR_2010Q1_revearnings1

Considering that the stock price of the company has been on a rise since December 2008, advancing 75% along the way, sharp correction today is justified. But for long-term investors, Minday Medical (NYSE:MR) remains a value stock that is priced right thanks to the double digit dip today. Buy into weakness - is the essence of the analysis above.

 



If you like us, spread the word to the fellow investors on your favorite Social Bookmarking websites
Reddit! Del.icio.us! Mixx! Free and Open Source Software News Google! Live! Facebook! StumbleUpon! TwitThis Joomla Free PHP
 

Online Courses

We train investors, people looking to become a trader, helping professionals wanting to be more effective in their work. See available courses.

advance_10
Register

Free weekly newsletter

Get hot China stock news every Monday